Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
564.5 EUR | -0.09% | -.--% | -.--% |
06-25 | Mirabaud Securities Lifts Price Target on EMS-Chemie Holding AG, Maintains Hold Recommendation | MT |
05-09 | Berenberg Lifts Price Target on EMS-Chemie, Maintains Hold Recommendation | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 38.61 and 34.67 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 19.17B | - | ||
+19.99% | 67.97B | A- | ||
-6.03% | 45.92B | A- | ||
+22.27% | 43.74B | B+ | ||
+33.20% | 28.16B | A- | ||
+14.71% | 17.12B | B+ | ||
-13.18% | 14.73B | B+ | ||
-27.99% | 14.52B | A- | ||
-32.33% | 11.64B | A- | ||
-33.89% | 11.23B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EMSN Stock
- EMC1 Stock
- Ratings EMS-CHEMIE HOLDING AG